The European Union's pharmaceutical sector is in a constant state of evolution. With rigorous regulations, increasing patient needs, and the swift pace of development, navigating this complex landscape requires a prudent approach. Pharmaceutical companies must adjust to this changes by implementing advanced technologies, collaborating with key stak